About Us
Ed Saltzman
President
esaltzman@definedhealth.com
Ed is founder and President of Defined Health, a leading consultancy in business development and disease area strategy for the pharmaceutical industry. Since its founding in 1983, Defined Health has completed thousands of opportunity assessments and commercial forecasts of development stage projects for hundreds of corporate clients across the Big Pharma, Biotechnology and Specialty Pharma complex. Defined Health’s length and breadth of experience in evaluating pipeline opportunities provides the firm with a unique and often unconventional spotlight on strategic issues confronting the industry, particularly with respect to the quality of the development pipeline and its implications for sustainability of established and evolving business models.
Ed is a noted speaker on industry strategy and was one of the earliest critics of the Pharma industry blockbuster business model and its over-dependence on in-licensing late-stage primary care blockbuster drugs to fuel growth. Ed was also one of the first to spot the limitation of the specialty pharma serial product acquisition model, and, as a result, he is much sought after for strategic guidance by specialty pharma and biotech companies facing sustainability challenges.
Ed began his involvement with the pharma industry at the Ayerst Laboratories unit of American Home Products, where he had responsibility for evaluation and forecasting of compounds being considered for licensing. Prior to Ayerst, he managed the Healthcare Information Center at FIND/SVP.
Ed is a member of the Licensing Executives Society and the New York Pharma Forum and is a graduate of New York University.